Sequoia Financial Advisors LLC Trims Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Sequoia Financial Advisors LLC lowered its position in iShares Biotechnology ETF (NASDAQ:IBB) by 29.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,060 shares of the financial services provider’s stock after selling 877 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in iShares Biotechnology ETF were worth $280,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in IBB. Vontobel Holding Ltd. increased its stake in iShares Biotechnology ETF by 9.5% in the 1st quarter. Vontobel Holding Ltd. now owns 5,060 shares of the financial services provider’s stock worth $659,000 after buying an additional 440 shares during the period. Blair William & Co. IL increased its position in iShares Biotechnology ETF by 9.7% during the 1st quarter. Blair William & Co. IL now owns 18,717 shares of the financial services provider’s stock valued at $2,439,000 after purchasing an additional 1,659 shares during the period. NewEdge Advisors LLC boosted its holdings in shares of iShares Biotechnology ETF by 11.7% in the 1st quarter. NewEdge Advisors LLC now owns 13,777 shares of the financial services provider’s stock valued at $1,796,000 after buying an additional 1,445 shares in the last quarter. DCF Advisers LLC bought a new stake in shares of iShares Biotechnology ETF in the 1st quarter valued at about $912,000. Finally, Laurel Wealth Advisors Inc. boosted its holdings in shares of iShares Biotechnology ETF by 22.6% in the 1st quarter. Laurel Wealth Advisors Inc. now owns 3,019 shares of the financial services provider’s stock valued at $393,000 after buying an additional 557 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $124.72 on Friday. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $141.16. The stock has a market capitalization of $6.93 billion, a P/E ratio of 16.28 and a beta of 0.84. The company’s 50-day simple moving average is $135.09 and its 200-day simple moving average is $129.54.

iShares Biotechnology ETF Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.40%. The ex-dividend date of this dividend was Thursday, March 21st.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.